Stoneridge Investment Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.29M | Sell |
7,029
-7,087
| -50% | -$1.31M | 0.93% | 31 |
|
|
2025
Q4 | $2.48M | Sell |
14,116
-483
| -3% | -$78.9K | 1.73% | 15 |
|
|
2025
Q3 | $2.04M | Hold |
14,599
| – | – | 1.4% | 17 |
|
|
2025
Q2 | $1.83M | Hold |
14,599
| – | – | 1.38% | 20 |
|
|
2025
Q1 | $2M | Sell |
14,599
-19,200
| -57% | -$2.74M | 1.69% | 18 |
|
|
2024
Q4 | $5.17M | Hold |
33,799
| – | – | 1.85% | 14 |
|
|
2024
Q3 | $6.55M | Buy |
33,799
+3,244
| +11% | +$679K | 2.44% | 10 |
|
|
2024
Q2 | $7.08M | Buy |
30,555
+681
| +2% | +$148K | 2.68% | 6 |
|
|
2024
Q1 | $6.44M | Buy |
29,874
+5,552
| +23% | +$1.3M | 2.45% | 8 |
|
|
2023
Q4 | $6.29M | Buy |
+24,322
| New | +$5.97M | 2.65% | 7 |
|
|
2023
Q3 | – | Sell |
-4,160
| Closed | -$1.19M | – | 103 |
|
|
2023
Q2 | $1.19M | Buy |
4,160
+695
| +20% | +$207K | 0.52% | 57 |
|
|
2023
Q1 | $963K | Buy |
+3,465
| New | +$959K | 0.51% | 62 |
|
|
2022
Q1 | – | Sell |
-2,694
| Closed | -$646K | – | 106 |
|
|
2021
Q4 | $646K | Hold |
2,694
| – | – | 0.3% | 81 |
|
|
2021
Q3 | $762K | Sell |
2,694
-1,140
| -30% | -$374K | 0.38% | 69 |
|
|
2021
Q2 | $1.33M | Buy |
3,834
+391
| +11% | +$118K | 0.65% | 50 |
|
|
2021
Q1 | $963K | Sell |
3,443
-1,763
| -34% | -$475K | 0.51% | 61 |
|
|
2020
Q4 | $1.27M | Buy |
+5,206
| New | +$1.34M | 0.74% | 43 |
|
|
2020
Q3 | – | Sell |
-4,468
| Closed | -$1.2M | – | 111 |
|
|
2020
Q2 | $1.2M | Sell |
4,468
-3,697
| -45% | -$1.11M | 0.5% | 65 |
|
|
2020
Q1 | $2.58M | Sell |
8,165
-3,082
| -27% | -$935K | 1.16% | 28 |
|
|
2019
Q4 | $3.34M | Buy |
11,247
+3,578
| +47% | +$993K | 1.13% | 27 |
|
|
2019
Q3 | $1.78M | Buy |
7,669
+2,078
| +37% | +$484K | 0.66% | 56 |
|
|
2019
Q2 | $1.31M | Sell |
5,591
-10,568
| -65% | -$2.44M | 0.46% | 72 |
|
|
2019
Q1 | $3.82M | Sell |
16,159
-30,758
| -66% | -$9.69M | 1.12% | 33 |
|
|
2018
Q4 | $14.1M | Sell |
46,917
-10,352
| -18% | -$3.3M | 4.43% | 2 |
|
|
2018
Q3 | $20.2M | Sell |
57,269
-21,477
| -27% | -$7.39M | 4.3% | 3 |
|
|
2018
Q2 | $22.9M | Buy |
78,746
+678
| +0.9% | +$191K | 4.41% | 1 |
|
|
2018
Q1 | $21.4M | Buy |
78,068
+26,291
| +51% | +$8.16M | 3.58% | 2 |
|
|
2017
Q4 | $16.5M | Sell |
51,777
-831
| -2% | -$267K | 2.64% | 2 |
|
|
2017
Q3 | $16.5M | Sell |
52,608
-3,391
| -6% | -$1M | 2.59% | 3 |
|
|
2017
Q2 | $15.2M | Buy |
55,999
+22,623
| +68% | +$5.98M | 2.26% | 4 |
|
|
2017
Q1 | $9.13M | Buy |
33,376
+16,910
| +103% | +$4.78M | 1.23% | 10 |
|
|
2016
Q4 | $4.67M | Buy |
+16,466
| New | +$4.88M | 0.64% | 51 |
|
|
2014
Q4 | – | Sell |
-3,818
| Closed | -$1.26M | – | 261 |
|
|
2014
Q3 | $1.26M | Buy |
+3,818
| New | +$1.26M | 0.19% | 146 |
|
Other funds holding BIIB
VCM
VPM
Stoneridge Investment Partners's BIIB Position: Q1 2026 in Review
Stoneridge Investment Partners reduced its Biogen (BIIB) stake by 50% in Q1 2026, selling an estimated $1.31M and leaving 7,029 shares worth $1.29M. The position accounts for 0.93% of the portfolio, ranked #31.
Stoneridge Investment Partners first reported a position in BIIB in Q3 2014 and has held it in 33 quarters since. The position peaked at $22.9M in Q2 2018. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Stoneridge Investment Partners held 7,029 shares of Biogen worth $1.29M as of Q1 2026.
- Stoneridge Investment Partners sold 7,087 Biogen shares in Q1 2026, an estimated $1.31M.
- Biogen made up 0.93% of Stoneridge Investment Partners's portfolio in Q1 2026, its #31 holding.
- Stoneridge Investment Partners first reported a position in Biogen in Q3 2014 and has held it in 33 quarters since.
- Stoneridge Investment Partners's Biogen position peaked at $22.9M in Q2 2018.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Stoneridge Investment Partners's 13F filing for Q1 2026, filed 6 May 2026.